Redcare, Pharmacy’s

Redcare Pharmacy’s Logistics Expansion Fails to Impress Investors

12.12.2025 - 13:02:05

Redcare Pharmacy NL0012044747

Despite making significant operational progress, Redcare Pharmacy's share price continues to languish near annual lows. The online pharmacy has officially launched a new logistics hub in Pilsen, Czech Republic, a move designed to bolster its service for the crucial Austrian market. However, this strategic development has done little to shift the stock from its technically weak position, leaving it trading within striking distance of its yearly lows.

The market's muted reaction highlights a clear divergence between the company's infrastructure growth and its current valuation. Investor attention remains fixed not on logistics, but on margin development and the adoption of electronic prescriptions in Germany. For now, the gap between Redcare's expanding operational network and its stock market performance appears to be widening.

From a chart perspective, the outlook remains difficult. Having declined approximately 60% over a twelve-month period, the shares are now battling to hold above a key support level around €60. The positive news from Pilsen has so far failed to generate any substantial buying interest.

Should investors sell immediately? Or is it worth buying Redcare Pharmacy?

The next critical juncture for a potential re-rating will arrive in March 2026 with the release of upcoming quarterly figures. These results will need to demonstrate whether the promised efficiency gains from the new facility are beginning to leave a visible mark on adjusted EBITDA. Until then, the equity faces the primary task of defending its current price floor.

Strategic Hub Aims to Capture Austrian Market Growth

The transition of logistics for Austrian customers from Sevenum in the Netherlands to Pilsen is now complete. This shift represents a tangible capacity increase, not merely an administrative change. The new center is engineered to handle up to 15 million additional packages of over-the-counter (OTC) medications annually.

Key strategic benefits of the Pilsen location include:
* Geographic Advantage: Proximity to the Austrian border enables substantially shorter transportation routes.
* Service Enhancement: Faster delivery times are expected to further improve customer satisfaction metrics, such as the Net Promoter Score.
* Operational Efficiency: Streamlined processes and lower logistics costs should boost overall efficiency.

Ad

Redcare Pharmacy Stock: Buy or Sell?! New Redcare Pharmacy Analysis from December 12 delivers the answer:

The latest Redcare Pharmacy figures speak for themselves: Urgent action needed for Redcare Pharmacy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 12.

Redcare Pharmacy: Buy or sell? Read more here...

@ boerse-global.de